We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NEOG market cap is 2.25B. The company's latest EPS is USD -0.0434 and P/E is -238.94.
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 228.99M | 229.63M | 228.81M | 236.79M | 216.96M |
| Operating Income | 19.14M | 14.47M | 12.02M | 13.04M | 2.26M |
| Net Income | 1.5M | -3.49M | -2.02M | -5.42M | -12.61M |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 418.17M | 468.46M | 527.16M | 822.45M | 924.22M |
| Operating Income | 67.52M | 74.17M | 58.62M | 37.52M | 58.66M |
| Net Income | 59.48M | 60.88M | 48.31M | -22.87M | -9.42M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.56B | 4.6B | 4.58B | 4.55B | 4.5B |
| Total Liabilities | 1.41B | 1.45B | 1.44B | 1.4B | 1.37B |
| Total Equity | 3.15B | 3.15B | 3.15B | 3.14B | 3.14B |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 797.18M | 920.19M | 992.93M | 4.55B | 4.55B |
| Total Liabilities | 72.01M | 79.82M | 105.56M | 1.42B | 1.4B |
| Total Equity | 725.18M | 840.38M | 887.37M | 3.13B | 3.14B |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 23.01M | 38.72M | 8.52M | 35.26M | -17.91M |
| Investing | -8.68M | 2.85M | -11.79M | -29.31M | -33.66M |
| Financing | 1.06M | 752k | 2M | 1.92M | 979k |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 85.88M | 81.09M | 68.04M | 41.03M | 35.26M |
| Investing | -88.79M | -105.56M | -97.23M | 201.04M | -29.31M |
| Financing | 29.41M | 33.54M | 6.81M | -118.08M | 1.92M |
| Market Cap | 2.25B |
| Price to Earnings Ratio | -238.94 |
| Price to Sales Ratio | 2.43 |
| Price to Cash Ratio | 13.19 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 216.94M |
| Average Volume (1 week) | 2.24M |
| Average Volume (1 Month) | 2.82M |
| 52 Week Change | -37.42% |
| 52 Week High | 18.58 |
| 52 Week Low | 10.27 |
| Spread (Intraday) | 0.26 (2.44%) |
| Company Name | Neogen Corporation |
| Address |
620 lesher place lansing, michigan 48912 |
| Website | https://www.neogen.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
